In this interview, Jordan Armstrong, chief revenue officer at ResultsCX, discusses how leading health plans are leveraging artificial intelligence (AI), automation, and personalized advocacy to simplify compliance, strengthen member trust,...
In this interview, Jordan Armstrong, chief revenue officer at ResultsCX, discusses how leading health plans are leveraging artificial intelligence (AI), automation, and personalized advocacy to simplify compliance, strengthen member trust,...
In this interview, Joe DePinto, head of Cell, Gene, and Advanced Therapies at McKesson, discusses the launch of InspiroCare—a cell- and gene-specific hub designed to remove barriers to patient access, streamline coordination across...
In this interview, Joe DePinto, head of Cell, Gene, and Advanced Therapies at McKesson, discusses the launch of InspiroCare—a cell- and gene-specific hub designed to remove barriers to patient access, streamline coordination across...
Seema A. Bhat, MD, a physician at The Ohio State University and a member of both the chronic lymphocytic leukemia (CLL) and hairy cell leukemia treatment groups, shared her expertise with First Report Managed Care on the evolving landscape of...
Seema A. Bhat, MD, a physician at The Ohio State University and a member of both the chronic lymphocytic leukemia (CLL) and hairy cell leukemia treatment groups, shared her expertise with First Report Managed Care on the evolving landscape of...
In this interview, Trushar Dungarani, DO, SFHM, discusses the importance of high-quality, accessible patient data for clinicians to enhance care delivery, address social determinants of health, and drive effective population health...
In this interview, Trushar Dungarani, DO, SFHM, discusses the importance of high-quality, accessible patient data for clinicians to enhance care delivery, address social determinants of health, and drive effective population health...
Learn about the impact of the 2024 Homecare Insights Survey on caregiver satisfaction and how specialized training, recognition, and technology can enhance patient care and support caregiver well-being.
Learn about the impact of the 2024 Homecare Insights Survey on caregiver satisfaction and how specialized training, recognition, and technology can enhance patient care and support caregiver well-being.
Guest experts weigh in on the ongoing issue of labor shortages in the health care homecare industry as well as solutions for maintaining a robust, engaged, and well-trained workforce.
Guest experts weigh in on the ongoing issue of labor shortages in the health care homecare industry as well as solutions for maintaining a robust, engaged, and well-trained workforce.
Discover how social determinants of health have historically been overlooked in health care, the obstacles preventing professionals from addressing them, and the potential consequences of reducing policy support in this eye-opening interview...
Discover how social determinants of health have historically been overlooked in health care, the obstacles preventing professionals from addressing them, and the potential consequences of reducing policy support in this eye-opening interview...
Discover how social determinants of health have historically been overlooked in healthcare, the obstacles preventing professionals from addressing them, and the potential consequences of reducing policy support in this eye-opening interview...
Discover how social determinants of health have historically been overlooked in healthcare, the obstacles preventing professionals from addressing them, and the potential consequences of reducing policy support in this eye-opening interview...
Learn about the impact of the 2024 Medicare Physician Fee Schedule, the importance of virtual care management services in chronic care, and how organizations like TimeDoc can help providers navigate the changing health care landscape.
Learn about the impact of the 2024 Medicare Physician Fee Schedule, the importance of virtual care management services in chronic care, and how organizations like TimeDoc can help providers navigate the changing health care landscape.
Guest expert and AMCP 2024 presenter Meron Gartner, PharmD, elaborates on how pharmacists play a crucial role in addressing social determinants of health by engaging with patients, identifying barriers, and connecting them to resources for...
Guest expert and AMCP 2024 presenter Meron Gartner, PharmD, elaborates on how pharmacists play a crucial role in addressing social determinants of health by engaging with patients, identifying barriers, and connecting them to resources for...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate and Editorial Board Member of First Report Managed Care—explores newly approved and existing anticoagulant therapies. He analyzes...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate and Editorial Board Member of First Report Managed Care—explores newly approved and existing anticoagulant therapies. He analyzes...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...